Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma

被引:34
|
作者
Zhang, Megan Q.
Lin, Fan
Hui, Pei
Chen, Zong-Ming E.
Ritter, Jon H.
Wang, Hanlin L.
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Lauren V Ackerman Lab Surg Pathol, St Louis, MO USA
[2] Geisinger Med Ctr, Dept Lab Med, Danville, PA 17822 USA
[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
small intestine; colorectal; adenocarcinoma; mucin; small-intestinal mucin antigen; villin; CDX2;
D O I
10.1309/JAF3KVGJHQCJ1QF9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Expression of gastrointestinal biomarkers MUCI, MUC2, MUC5AC, small-intestinal mucin antigen (SIMA), villin, and CDX2 has been studied in colorectal adenocarcinoma (CRC). Little is known, however, about their expression in small-intestinal adenocarcinoma (SIA). We immunohistochemically compared 30 SIAs with 48 CRCs for the expression of these biomarkers. The results showed that all 6 proteins were variably expressed in SIA, but the frequencies of expression were significantly lower than those for CRC with the exception of MUC1 Specifically, positive staining for MUCI, MUC2, MUC5AC, SIMA villin, and CDX2 was observed in 16 (53%), 17 (57%), 12 (40%), 15 (50%), 20 (67%), and 18 (60%) of SlAs and 25 (52%), 43 (90%), 39 (81%), 45 (94%), 47 (98%), and 47 (98%) of CRCs, respectively. In addition, SIAs morefrequently exhibited afocal staining pattern for MUC2, MUC5AC, SIMA, and villin, whereas more diffuse immunoreactivity was evident in CRCs. Focal staining for MUCI and diffuse staining for CDX2 were common for SIAs and CRCs. Furthermore, poorly differentiated SIAs tended to express MUCI more frequently when compared with well- and moderately differentiated SIAs. These observations further support the notion that SIA is immunophenotypically distinct from CRC despite their morphologic similarity.
引用
收藏
页码:808 / 816
页数:9
相关论文
共 50 条
  • [31] CDX2 Expression in Primary and Metastatic Prostatic Adenocarcinoma: A Retrospective Study
    Girardo, C.
    Fakhri, N.
    Khokhar, H.
    Jetly, R.
    Bhalla, R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S59 - S60
  • [32] Interpretation of diffuse Cdx2 expression in endometrioid adenocarcinoma in the absence of morules
    Wani, Yoji
    HISTOPATHOLOGY, 2009, 54 (04) : 495 - 497
  • [33] Differential regulation of intestinal alkaline phosphatase gene expression by Cdx1 and Cdx2
    Alkhoury, F
    Malo, MS
    Mozumder, M
    Mostafa, G
    Hodin, RA
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 289 (02): : G285 - G290
  • [34] Expression and Functional Role of Cdx2 in Intestinal Metaplasia of Cystitis Glandularis
    Lin, Ming-en
    Huang, Danying
    Deng, Bi-hua
    Lv, Yi-song
    Rong, Lu
    Yao, You-sheng
    JOURNAL OF UROLOGY, 2013, 190 (03): : 1083 - 1089
  • [35] CDX2 as marker of intestinal differentiation with altered expression in colorectal carcinomas
    Isa, M. R.
    Haryati, H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A87 - A87
  • [36] Does CDx2 Provoke Expression of Intestinal Genes in Oesophageal Cells?
    Colleypriest, Benjamin J.
    Farrant, John M.
    Slack, Jonathan M.
    Tosh, David
    GASTROENTEROLOGY, 2009, 136 (05) : A49 - A49
  • [37] CDX2 as a Prognostic Marker in Gastric Adenocarcinoma
    Masood, Muhammad A.
    Yusuf, Muhammed A.
    Loya, Asif
    LABORATORY INVESTIGATION, 2016, 96 : 186A - 186A
  • [38] CDX2 as a Prognostic Marker in Gastric Adenocarcinoma
    Masood, Muhammad A.
    Yusuf, Muhammad A.
    Loya, Asif
    MODERN PATHOLOGY, 2016, 29 : 186A - 186A
  • [39] CDX2 in diagnosis of pancreatic ductal adenocarcinoma
    Khadija, B.
    Neji, M.
    Ajouli, W.
    Dhaoui, A.
    Sdiri, A.
    Ben Ghachem, D.
    VIRCHOWS ARCHIV, 2014, 465 : S311 - S312
  • [40] Epigenetic changes of CDX2 in gastric adenocarcinoma
    Samadani, Ali Akbar
    Nikbakhsh, Novin
    Pilehchian, Maryam
    Fattahi, Sadegh
    Akhavan-Niaki, Haleh
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2016, 10 (04) : 267 - 272